![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 17, 13881-13890, April 27, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the The double-stranded RNA (dsRNA)-activated protein
kinase PKR (protein kinase
dsRNA-dependent) plays an important role in the regulation of protein synthesis by phosphorylating the
Dominant Negative Function by an Alternatively Spliced
Form of the Interferon-inducible Protein Kinase PKR*
and
§¶
Lady Davis Institute for Medical Research,
Sir Mortimer B. Davis-Jewish General Hospital, Montréal,
Québec H3T 1E2, Canada and the § Departments of
Oncology, Medicine, Microbiology and Immunology, and Cell Biology and
Anatomy, McGill University, Montréal, Québec H3A
2B4, Canada
-subunit of
eukaryotic initiation factor 2. Through this activity, PKR is thought
to mediate the antiviral and antiproliferative actions of interferon.
Here, we show that the human T cell leukemia Jurkat cells express an
alternatively spliced form of PKR with a deletion of exon 7 (PKR
E7),
resulting in a truncated protein that retains the two dsRNA-binding
motifs. PKR
E7 exhibits a dominant negative function by inhibiting
both PKR autophosphorylation and eukaryotic initiation factor 2
-subunit phosphorylation in vitro and in vivo. Reverse transcriptase-polymerase chain reaction assays
showed that PKR
E7 is expressed in a broad range of human tissues at variable levels. Interestingly, expression of PKR
E7 is higher in
Jurkat cells than in normal peripheral blood mononuclear cells, raising
the possibility of a role in cell proliferation and/or transformation.
Thus, expression of alternatively spliced forms of PKR may represent a
novel mechanism of PKR autoregulation with important implications in
the control of cell proliferation.
*
This work was supported by a grant and a postdoctoral
fellowship from the Cancer Research Society Inc. (to A. E. K. and
S. L., respectively).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
J. F. Raven, D. Baltzis, S. Wang, Z. Mounir, A. I. Papadakis, H. Q. Gao, and A. E. Koromilas PKR and PKR-like Endoplasmic Reticulum Kinase Induce the Proteasome-dependent Degradation of Cyclin D1 via a Mechanism Requiring Eukaryotic Initiation Factor 2{alpha} Phosphorylation J. Biol. Chem., February 8, 2008; 283(6): 3097 - 3108. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Su, S. Wang, H. Q. Gao, S. Kazemi, H. P. Harding, D. Ron, and A. E. Koromilas Modulation of the Eukaryotic Initiation Factor 2 {alpha}-Subunit Kinase PERK by Tyrosine Phosphorylation J. Biol. Chem., January 4, 2008; 283(1): 469 - 475. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Garcia, J. Gil, I. Ventoso, S. Guerra, E. Domingo, C. Rivas, and M. Esteban Impact of Protein Kinase PKR in Cell Biology: from Antiviral to Antiproliferative Action Microbiol. Mol. Biol. Rev., December 1, 2006; 70(4): 1032 - 1060. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Su, S. Wang, D. Baltzis, L.-K. Qu, A. H.-T. Wong, and A. E. Koromilas Tyrosine phosphorylation acts as a molecular switch to full-scale activation of the eIF2alpha} RNA-dependent protein kinase. PNAS, January 3, 2006; 103(1): 63 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Melchjorsen, S. B. Jensen, L. Malmgaard, S. B. Rasmussen, F. Weber, A. G. Bowie, S. Matikainen, and S. R. Paludan Activation of Innate Defense against a Paramyxovirus Is Mediated by RIG-I and TLR7 and TLR8 in a Cell-Type-Specific Manner J. Virol., October 15, 2005; 79(20): 12944 - 12951. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rothenburg, N. Deigendesch, K. Dittmar, F. Koch-Nolte, F. Haag, K. Lowenhaupt, and A. Rich A PKR-like eukaryotic initiation factor 2{alpha} kinase from zebrafish contains Z-DNA binding domains instead of dsRNA binding domains PNAS, February 1, 2005; 102(5): 1602 - 1607. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kazemi, S. Papadopoulou, S. Li, Q. Su, S. Wang, A. Yoshimura, G. Matlashewski, T. E. Dever, and A. E. Koromilas Control of {alpha} Subunit of Eukaryotic Translation Initiation Factor 2 (eIF2{alpha}) Phosphorylation by the Human Papillomavirus Type 18 E6 Oncoprotein: Implications for eIF2{alpha}-Dependent Gene Expression and Cell Death Mol. Cell. Biol., April 15, 2004; 24(8): 3415 - 3429. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Pang, T. A. Christianson, T. Koretsky, H. Carlson, L. David, W. Keeble, G. R. Faulkner, A. Speckhart, and G. C. Bagby Nucleophosmin Interacts with and Inhibits the Catalytic Function of Eukaryotic Initiation Factor 2 Kinase PKR J. Biol. Chem., October 24, 2003; 278(43): 41709 - 41717. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sasaki, K. Inagaki-Ohara, T. Yoshida, A. Yamanaka, M. Sasaki, H. Yasukawa, A. E. Koromilas, and A. Yoshimura The N-terminal Truncated Isoform of SOCS3 Translated from an Alternative Initiation AUG Codon under Stress Conditions Is Stable Due to the Lack of a Major Ubiquitination Site, Lys-6 J. Biol. Chem., January 17, 2003; 278(4): 2432 - 2436. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Baltzis, S. Li, and A. E. Koromilas Functional Characterization of pkr Gene Products Expressed in Cells from Mice with a Targeted Deletion of the N terminus or C terminus Domain of PKR J. Biol. Chem., October 4, 2002; 277(41): 38364 - 38372. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Rivas-Estilla, Y. Svitkin, M. Lopez Lastra, M. Hatzoglou, A. Sherker, and A. E. Koromilas PKR-Dependent Mechanisms of Gene Expression from a Subgenomic Hepatitis C Virus Clone J. Virol., October 2, 2002; 76(21): 10637 - 10653. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |